Antianxiety treatment in patients with excessive hypertension

被引:44
作者
Grossman, E [1 ]
Nadler, M
Sharabi, Y
Thaler, M
Shachar, A
Shamiss, A
机构
[1] Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Internal Med D & Hypertens Unit, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Dept Emergency Med, IL-52621 Tel Hashomer, Israel
关键词
hypertensive crisis; captopril; anxiolytic agent;
D O I
10.1016/j.amjhyper.2005.03.728
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective: There are no guidelines on how to treat patients with excessive hypertension. Anxiety is a common cause of excessive hypertension and therefore antianxiety treatment may be beneficial in these patients. We therefore compared the efficacy and safety of antianxiety treatment with sublingual captopril administration in patients with excessive hypertension and no evidence of acute target organ damage. Methods: Thirty-six patients (28 women and 8 men), mean age 60 +/- 2 years (range 36 to 85 years) who were referred to the emergency room because of excessive hypertension (> 190/100 mm Hg) without evidence of acute target organ damage were randomized to receive either oral diazepam, 5 mg (n = 17, study group) or sublingual captopril, 25 mg (n = 19, control group). Blood pressure (BP) and heart rate were recorded hourly for 3 h. Results: Both treatments decreased BP significantly (from 213 +/- 5/105 +/- 3 to 170 +/- 8/88 +/- 6 mm Hg in the study group, and from 208 +/- 5/107 +/- 3 to 181 +/- 8/95 +/- 3 mm Hg in the control group (P < .01 v initial BP). One patient in each group was hospitalized because of sustained excessive hypertension. Conclusions: Antianxiety treatment is effective in lowering BP in patients with excessive hypertension. Thus, anxiolytic treatment may be considered in patients with excessive hypertension without acute target organ damage. Further large placebo controlled studies are required to prove the benefit of anxiolytic agents.
引用
收藏
页码:1174 / 1177
页数:4
相关论文
共 18 条
[1]  
ABRAHAM G, 1986, BRIT J CLIN PRACT, V40, P478
[2]   COMPARISON OF SUBLINGUAL CAPTOPRIL AND NIFEDIPINE IN IMMEDIATE TREATMENT OF HYPERTENSIVE EMERGENCIES - A RANDOMIZED, SINGLE-BLIND CLINICAL-TRIAL [J].
ANGELI, P ;
CHIESA, M ;
CAREGARO, L ;
MERKEL, C ;
SACERDOTI, D ;
RONDANA, M ;
GATTA, A .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (04) :678-682
[3]  
BUSSMANN WD, 1992, CLIN INVESTIGATOR, V70, P1085
[4]  
CALHOUN DA, 1990, NEW ENGL J MED, V323, P1177
[5]   MANAGEMENT OF HYPERTENSIVE CRISES [J].
GIFFORD, RW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (06) :829-835
[6]  
GOLDSTEIN DS, 1991, HYPERTENSION S3, V18, P40
[7]   Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? [J].
Grossman, E ;
Messerli, FH ;
Grodzicki, T ;
Kowey, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (16) :1328-1331
[8]   Comparative tolerability profile of hypertensive crisis treatments [J].
Grossman, E ;
Ironi, AN ;
Messerli, FH .
DRUG SAFETY, 1998, 19 (02) :99-122
[9]  
HASDAI D, 1992, ARCH INTERN MED, V152, P1725, DOI 10.1001/archinte.152.8.1725
[10]  
HOUSTON MC, 1986, AM HEART J, V111, P963, DOI 10.1016/0002-8703(86)90647-2